Compare · CTVA vs RKDA
CTVA vs RKDA
Side-by-side comparison of Corteva Inc. (CTVA) and Arcadia Biosciences Inc. (RKDA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTVA and RKDA operate in Farming/Seeds/Milling (Consumer Staples), so they compete in similar markets.
- CTVA is the larger of the two at $50.74B, about 26672.6x RKDA ($1.9M).
- Over the past year, CTVA is up 5.5% and RKDA is down 81.6% - CTVA leads by 87.1 points.
- CTVA has hit the wire 3 times in the past 4 weeks while RKDA has been quiet.
- CTVA has more recent analyst coverage (25 ratings vs 1 for RKDA).
- Company
- Corteva Inc.
- Arcadia Biosciences Inc.
- Price
- $75.97-1.38%
- $0.92-12.61%
- Market cap
- $50.74B
- $1.9M
- 1M return
- -3.99%
- -20.90%
- 1Y return
- +5.49%
- -81.61%
- Industry
- Farming/Seeds/Milling
- Farming/Seeds/Milling
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2015
- News (4w)
- 3
- 0
- Recent ratings
- 25
- 1
Corteva Inc.
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. is headquartered in Wilmington, Delaware.
Arcadia Biosciences Inc.
Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; and nutritional oils, such as gamma linolenic acid oils. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Argentina, Canada, Africa, Austria, and India. The company was incorporated in 2002 and is headquartered in Davis, California.
Latest CTVA
- CEO, Crop Protection Business Kissam Luther C Iv was granted 24,138 shares, increasing direct ownership by 2,414% to 25,138 units (SEC Form 4)
- New insider Kissam Luther C Iv claimed ownership of 1,000 shares (SEC Form 3)
- Corteva Announces Dates for Second Quarter 2026 Earnings Release and Webcast
- SEC Form SCHEDULE 13G filed by Corteva Inc.
- Corteva Announces Headquarters for Two Future Companies Following Planned Separation
- Corteva to Participate in BMO Global Farm to Market Conference
- SEC Form 10-Q filed by Corteva Inc.
- SEC Form SCHEDULE 13G filed by Corteva Inc.
- Corteva Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
Latest RKDA
- SEC Form 10-Q filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
- Amendment: SEC Form 10-K/A filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- SEC Form 10-K filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights
- SEC Form EFFECT filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits